Home/Pipeline/TB Diagnostic & Drug Discovery

TB Diagnostic & Drug Discovery

Tuberculosis

Research/DiscoveryActive

Key Facts

Indication

Tuberculosis

Phase

Research/Discovery

Status

Active

Company

Avesthagen

About Avesthagen

Avesthagen leverages population genetics and systems biology through The Avestagenome Project® to develop predictive diagnostics and personalized healthcare solutions.

View full company profile

Therapeutic Areas

Oncology Infectious Disease

Other Tuberculosis Drugs

Drug	Company	Phase	Status
Vaxine TB Vaccine	Vaxine	Preclinical	Active
Isoniazid Oral Solution, USP	CMP Pharma	Approved	Marketed
Tuberculosis Program	Fimbrion Therapeutics	Preclinical	Active
Undisclosed Program	Crestone	Preclinical	Active
Tuberculosis Diagnostic	GenEndeavor	Research/Exploratory	Active
TB Screening LFA	DiagMetrics	Development	Active
RGFields for Tuberculosis	Anapole Technologies	Pre-clinical	Active
Tuberculosis Nanobody	VicuTec Biologicals	Pre-clinical	Active
Not specified on provided pages	Cadila Pharmaceuticals	Commercial (World's First Claim)	Marketed
ALF Platform	Senzo	Pre-clinical	Active
Satiro Tablets	KYORIN Pharmaceutical	Registration	Active (In-licensed for Japan)